Josh Mandel-Brehm
Directeur/Bestuurslid bij PROMIS NEUROSCIENCES, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Josh Mandel-Brehm
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur/Bestuurslid | 01-09-2021 | - |
| Independent Dir/Board Member | 01-09-2021 | - | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 01-05-2017 | - |
| Algemeen Directeur | 01-05-2017 | - | |
| President | 01-05-2017 | - | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Directeur/Bestuurslid | 01-09-2019 | - |
| Oprichter | 01-09-2019 | - |
Loopbaan van Josh Mandel-Brehm
Opleiding van Josh Mandel-Brehm
| University of Michigan | Masters Business Admin |
| Washington University in St. Louis | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Nederland | 2 |
| Canada | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Beurs
- Insiders
- Josh Mandel-Brehm
- Ervaring
